Nuvation Bio Inc. (NUVB) Reports In-Line Q2 EPS

Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $4.83 million versus the consensus estimate of $416.67 thousand.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Chemours reaches $450M settlement over PFAS pollution at four sites
• GraniteShares 2x Long SpaceX Daily ETF (SPAL) call put ratio 1.9 calls to 1 put
• Paychex beats fourth quarter EPS estimates, stock slides